This article explores the significant advancements in CAR-T therapy and its transition from academic centers to community practices. CAR-T therapy, a revolutionary treatment for certain hematological malignancies, involves modifying a patient’s T-cells to target and destroy cancer cells. Historically limited to later lines of treatment due to potential side effects and the need for individualized manufacturing, recent data supports its use in earlier lines of therapy.
Discover the importance of bridging education gaps among community healthcare providers, building outpatient infrastructure with manufacturer collaboration and facilitating referral shifts from specialized centers to community practices.
Understand the challenges faced by community cancer centers in providing CAR-T therapies and the need for comprehensive training programs, collaborative efforts and patient-centered care.
To learn more about how EVERSANA is advancing CAR-T therapy to community practices and the strategies to overcome associated challenges, download the full article now and discover how these innovations can transform patient care.
Author
Anne Marie is helping EVERSANA deliver value to stakeholders across the life sciences industry. Through her multi-decade career at prominent large and small pharmaceutical companies, she has become a proven biopharma leader driving cross-functional…
Barry Vucsko has more than 25 years of marketing, advertising, and consulting experience spanning more than 100 brands and several continents...
Jordan Schell is an Associate Partner at EVERSANA MANAGEMENT CONSULTING. With 15 years of life sciences experience, he has worked across large, mid-size, and start-up pharmaceutical and biotech companies to define, execute, and deliver…
Vanitha brings more than 20 years of experience in the area of medical communications and medical strategy. She is passionate about bringing medical science and storytelling together. She has training in both biomedicine and…
Jordan is a Senior Consultant with EVERSANA MANAGEMENT CONSULTING, specializing in direct-to-patient strategy, go-to-market strategy, pricing and market access, market research, and client and project management. Prior to joining EVERSANA, Jordan was a Senior…